Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy. [PDF]
Fiore G +14 more
europepmc +1 more source
Bovine Lactoferrin Enhances Toll-like Receptor 7 Response in Plasmacytoid Dendritic Cells and Modulates Cellular Immunity. [PDF]
Yago T +6 more
europepmc +1 more source
Integrin αvβ3 Limits Cytokine Production by Plasmacytoid Dendritic Cells and Restricts TLR-Driven Autoimmunity. [PDF]
Lorant AK +7 more
europepmc +1 more source
Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling. [PDF]
Monti M +5 more
europepmc +1 more source
The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond. [PDF]
Ngo C, Garrec C, Tomasello E, Dalod M.
europepmc +1 more source
Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer. [PDF]
Tiberio L +7 more
europepmc +1 more source
Toll-Like Receptor 8 is Expressed in Monocytes in Contrast to Plasmacytoid Dendritic Cells and Mediates Aberrant Interleukin-10 Responses in Patients With Systemic Sclerosis. [PDF]
Ehlers C +10 more
europepmc +1 more source
The multifaceted biology of plasmacytoid dendritic cells [PDF]
Plasmacytoid dendritic cells (pDCs) are a unique DC subset that specializes in the production of type I interferons (IFNs). pDCs promote antiviral immune responses and have been implicated in the pathogenesis of autoimmune diseases that are characterized by a type I IFN signature. However, pDCs can also induce tolerogenic immune responses.
Marco Colonna +2 more
exaly +3 more sources

